Transaction · 0001104659-26-015325

Aiello Joshua

Aiello Joshua, PAO, reported a transaction classified as grant at Orchestra BioMed Holdings, Inc. involving 70000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 70000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code APAO
OBIOOrchestra BioMed Holdings, Inc.
Filing timeFeb 13
Trade dateFeb 12, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$3.83
Pre-filing
1mo ago +11.7%1w ago -3.1%1d ago +5.7%
Returns since
7d +2.3%30d +9.7%90d +7.3%180d +15.4%1y +41.3%

OBIO price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
OBIO since 2026-02-13Filed 202 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001104659-26-015325
Stock Option (Right to Buy)
Transaction date
Feb 12, 2026
Filed Feb 13, 2026, 10:02 PM · 1d delay
Shares
70.0k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
70.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Principal Accounting Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The stock options will vest as follows: (i) 25% of the stock options will vest on February 12, 2027 (the "Vesting Commencement Date") and (ii) the remaining 75% stock options will vest in equal insta…

Original filing · 0001104659-26-015325
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

OBIO